SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-264966
Filing Date
2021-09-03
Accepted
2021-09-03 07:16:01
Documents
14
Period of Report
2021-09-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d224171d8k.htm   iXBRL 8-K 26537
2 EX-10.1 d224171dex101.htm EX-10.1 73748
6 GRAPHIC g224171g0902064543161.jpg GRAPHIC 2311
  Complete submission text file 0001193125-21-264966.txt   241083

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA atnx-20210901.xsd EX-101.SCH 2887
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE atnx-20210901_lab.xml EX-101.LAB 18137
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atnx-20210901_pre.xml EX-101.PRE 11404
7 EXTRACTED XBRL INSTANCE DOCUMENT d224171d8k_htm.xml XML 3344
Mailing Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203
Business Address 1001 MAIN STREET SUITE 600 BUFFALO NY 14203 716-898-8625
Athenex, Inc. (Filer) CIK: 0001300699 (see all company filings)

IRS No.: 431985966 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38112 | Film No.: 211235125
SIC: 2834 Pharmaceutical Preparations